These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 7508875)

  • 1. Troglitazone prevents glucose-induced insulin resistance of insulin receptor in rat-1 fibroblasts.
    Kellerer M; Kroder G; Tippmer S; Berti L; Kiehn R; Mosthaf L; Häring H
    Diabetes; 1994 Mar; 43(3):447-53. PubMed ID: 7508875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention by protein kinase C inhibitors of glucose-induced insulin-receptor tyrosine kinase resistance in rat fat cells.
    Müller HK; Kellerer M; Ermel B; Mühlhöfer A; Obermaier-Kusser B; Vogt B; Häring HU
    Diabetes; 1991 Nov; 40(11):1440-8. PubMed ID: 1657668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Troglitazone prevents hyperglycemia-induced but not glucosamine-induced insulin resistance.
    Miles PD; Higo K; Romeo OM; Lee MK; Rafaat K; Olefsky JM
    Diabetes; 1998 Mar; 47(3):395-400. PubMed ID: 9519745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute and chronic effects of troglitazone (CS-045) on isolated rat ventricular cardiomyocytes.
    Bähr M; Spelleken M; Bock M; von Holtey M; Kiehn R; Eckel J
    Diabetologia; 1996 Jul; 39(7):766-74. PubMed ID: 8817100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucose-induced translocation of protein kinase C isoforms in rat-1 fibroblasts is paralleled by inhibition of the insulin receptor tyrosine kinase.
    Berti L; Mosthaf L; Kroder G; Kellerer M; Tippmer S; Mushack J; Seffer E; Seedorf K; Häring H
    J Biol Chem; 1994 Feb; 269(5):3381-6. PubMed ID: 7508912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TNF-alpha-induced insulin resistance in vivo and its prevention by troglitazone.
    Miles PD; Romeo OM; Higo K; Cohen A; Rafaat K; Olefsky JM
    Diabetes; 1997 Nov; 46(11):1678-83. PubMed ID: 9356012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic effects of troglitazone on fructose-induced insulin resistance in the rat.
    Lee MK; Miles PD; Khoursheed M; Gao KM; Moossa AR; Olefsky JM
    Diabetes; 1994 Dec; 43(12):1435-9. PubMed ID: 7958495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Troglitazone treatment increases protein kinase B phosphorylation in skeletal muscle of normoglycemic subjects at risk for the development of type 2 diabetes.
    Meyer MM; Levin K; Grimmsmann T; Perwitz N; Eirich A; Beck-Nielsen H; Klein HH
    Diabetes; 2002 Sep; 51(9):2691-7. PubMed ID: 12196460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of troglitazone, a new oral antidiabetic agent, on fructose-induced insulin resistance.
    Yagi N; Takasu N; Higa S; Ishikawa K; Murakami K; Mimura G
    Horm Metab Res; 1995 Oct; 27(10):439-41. PubMed ID: 8575720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effect of the antidiabetic thiazolidinediones troglitazone and pioglitazone on human platelet aggregation mechanism.
    Ishizuka T; Itaya S; Wada H; Ishizawa M; Kimura M; Kajita K; Kanoh Y; Miura A; Muto N; Yasuda K
    Diabetes; 1998 Sep; 47(9):1494-500. PubMed ID: 9726240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thiazolidine derivatives ameliorate high glucose-induced insulin resistance via the normalization of protein-tyrosine phosphatase activities.
    Maegawa H; Ide R; Hasegawa M; Ugi S; Egawa K; Iwanishi M; Kikkawa R; Shigeta Y; Kashiwagi A
    J Biol Chem; 1995 Mar; 270(13):7724-30. PubMed ID: 7535776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic effects of troglitazone in the Goto-Kakizaki rat, a non-obese and normolipidemic rodent model of non-insulin-dependent diabetes mellitus.
    O'Rourke CM; Davis JA; Saltiel AR; Cornicelli JA
    Metabolism; 1997 Feb; 46(2):192-8. PubMed ID: 9030828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic effects of troglitazone on fat-induced insulin resistance in the rat.
    Khoursheed M; Miles PD; Gao KM; Lee MK; Moossa AR; Olefsky JM
    Metabolism; 1995 Nov; 44(11):1489-94. PubMed ID: 7476339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of troglitazone and D-chiroinositol on glucosamine-induced insulin resistance in vivo in rats.
    Yoshino K; Takeda N; Sugimoto M; Nakashima K; Okumura S; Hattori J; Sasaki A; Kawachi S; Takami K; Takami R; Yasuda K
    Metabolism; 1999 Nov; 48(11):1418-23. PubMed ID: 10582551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of troglitazone on dexamethasone-induced insulin resistance in rats.
    Okumura S; Takeda N; Takami K; Yoshino K; Hattori J; Nakashima K; Sugimoto M; Ishimori M; Takami R; Yasuda K
    Metabolism; 1998 Mar; 47(3):351-4. PubMed ID: 9500576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pioglitazone ameliorates high glucose induced desensitization of insulin receptor kinase in Rat 1 fibroblasts in culture.
    Maegawa H; Tachikawa-Ide R; Ugi S; Iwanishi M; Egawa K; Kikkawa R; Shigeta Y; Kashiwagi A
    Biochem Biophys Res Commun; 1993 Dec; 197(3):1078-82. PubMed ID: 8280122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute non-insulin-like stimulation of rat muscle glucose metabolism by troglitazone in vitro.
    Fürnsinn C; Neschen S; Noe C; Bisschop M; Roden M; Vogl C; Schneider B; Waldhäusl W
    Br J Pharmacol; 1997 Dec; 122(7):1367-74. PubMed ID: 9421284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Troglitazone: review and assessment of its role in the treatment of patients with impaired glucose tolerance and diabetes mellitus.
    Johnson MD; Campbell LK; Campbell RK
    Ann Pharmacother; 1998 Mar; 32(3):337-48. PubMed ID: 9533065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute effect of troglitazone on glucose metabolism in the absence or presence of insulin in perfused rat hindlimb.
    Okuno A; Ikeda K; Shiota M; Fujiwara T; Yoshioka S; Sugano T; Horikoshi H
    Metabolism; 1997 Jun; 46(6):716-21. PubMed ID: 9186311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-terminus or juxtamembrane deletions in the insulin receptor do not affect the glucose-dependent inhibition of the tyrosine kinase activity.
    Mosthaf L; Berti L; Kellerer M; Mushack J; Seffer E; Bossenmaier B; Coghlan M; Siddle K; Ullrich A; Häring HU
    Eur J Biochem; 1995 Feb; 227(3):787-91. PubMed ID: 7867639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.